Revelation Biosciences Inc
(NAS:REVB)
$
1.86
-0.01 (-0.53%)
Market Cap: 3.04 Mil
Enterprise Value: 9.23 Mil
PE Ratio: 0
PB Ratio: 0.32
GF Score: 22/100 Revelation Biosciences Inc at ROTH Conference Transcript
Mar 14, 2023 / 07:30PM GMT
Release Date Price:
$57.3
(+10.09%)
Jonathan Aschoff
ROTH Capital Partners, LLC - Analyst
Hello, welcome back. I'm Jonathan Aschoff, senior biotechnology analyst at ROTH MKM. And with me is James Rolke, the CEO of Revelation Biosciences. And welcome, James. Nice to have you.
James Rolke
Revelation Biosciences, Inc. - Director & CEO
Yeah, thanks for having me.
Jonathan Aschoff
ROTH Capital Partners, LLC - Analyst
I'm going to start you off with -- tell us a little bit about both of your lead programs, 100 and 300.
James Rolke
Revelation Biosciences, Inc. - Director & CEO
Yeah, great. Thanks. So just for the audience and for the people that are joining via their webcam, I'm going to cover a lot of information, I'm sure, as we go back and forth here and you can probably find a lot of what I'm going to tell you, including the data, on our website at revbiosciences.com. That's revbiosciences.com.
So yeah -- so I'm also very excited to tell you about our lead programs because I feel very
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot